Search results
Gateway - Quartz
Quartz· 35 minutes agoNovo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy, is set to report its first quarter earnings on May 2. The Danish pharma giant is one-half ...
Monica Treat — Making Medicare Painless
Arkansas Money & Politics· 5 days agoMonica Treat is on a mission to help seniors untangle the Gordian Knot of Medicare. As owner of Treat Insurance Agency, an independent provider of...
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
CNBC· 10 hours agoSkyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new...
Michigan’s largest insurer to drop weight-loss drug coverage - Indianapolis Business Journal
Indianapolis Business Journal· 6 days agoWeight-loss drugs from Novo Nordisk A/S and Indianapolis-based Eli Lilly and Co. will lose coverage...
The 'Chilling' Trump Plan That Could Pave The Way For Authoritarianism
HuffPost via Yahoo News· 6 days agoSpielberger, a policy counsel at the Project on Government Oversight who has raised alarms over how...
Fact check: Trump falsely claims Biden didn’t lower Americans’ insulin costs | CNN Politics
CNN.com· 3 days agoPresident Joe Biden is campaigning on his success in getting seniors with diabetes a $35-per-month...
Inland Empire Health Plan certified a Great Place To Work® for fourth year in a row
WKRN Nashville· 4 days agoInland Empire Health Plan (IEHP) is a Great Place To Work®, according to 92% of team members surveyed about their experience working for the Rancho Cucamonga-based health ...
Fact check: Trump falsely claims Biden didn’t lower Americans’ insulin costs
WKBT La Crosse· 3 days agoPresident Joe Biden is campaigning on his success in getting seniors with diabetes a $35-per-month cap on their insulin spending. Facts First: Trump’s claims that Biden did nothing to lower ...
JD Supra: Health Care Week in Review: House Held a Markup of Telehealth Legislation; CMS Introduced...
JD Supra· 5 days agoBelow is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee ...
Compelling Reasons to Hold on to Cigna (CI) Stock for Now
Zacks· 18 hours agoFree Report) continues to be aided by two solid growth platforms, acquisitions and a solid financial position. Cigna carries a Zacks Rank #3 (Hold), at present. The stock has gained 24% in the ...
